Amarin Corporation plc (AMRN)
NASDAQ: AMRN · Real-Time Price · USD
10.60
-0.31 (-2.84%)
May 5, 2025, 4:00 PM EDT - Market closed
Amarin Corporation Employees
Amarin Corporation had 275 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
275
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$831,324
Profits / Employee
-$298,847
Market Cap
219.52M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
AMRN News
- 6 days ago - Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 7 days ago - Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 - GlobeNewsWire
- 21 days ago - Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday - Benzinga
- 26 days ago - Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change - GlobeNewsWire
- 4 weeks ago - Amarin Appoints JEC Capital Partners' Michael Torok to Board of Directors - GlobeNewsWire
- 6 weeks ago - Concerned Shareholder Group Urges Amarin's Board of Directors to Initiate a Strategic Review Following Two Years of Underperformance - Business Wire
- 6 weeks ago - New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo - GlobeNewsWire
- 7 weeks ago - Amarin Corporation plc (AMRN) Q4 2024 Earnings Call Transcript - Seeking Alpha